MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ
26.52
+0.57
+2.20%
Closed 16:20 12/06 EST
OPEN
25.98
PREV CLOSE
25.95
HIGH
27.00
LOW
25.98
VOLUME
172.06K
TURNOVER
0
52 WEEK HIGH
44.09
52 WEEK LOW
23.09
MARKET CAP
785.87M
P/E (TTM)
-12.4082
1D
5D
1M
3M
1Y
5Y
UBS Initiates Coverage On Fulgent Genetics with Neutral Rating, Announces Price Target of $35
Benzinga · 2h ago
Fulgent Genetics: Statement of changes in beneficial ownership of securities
Press release · 14h ago
Fulgent Genetics: Report of proposed sale of securities
Press release · 2d ago
Weekly Report: what happened at FLGT last week (1127-1201)?
Weekly Report · 3d ago
Following Up On Fulgent Genetics
Fulgent genetics, inc. Is a diagnostic company that is navigating through the 'covid cliff' after the pandemic. The company's "core" sales growth should return in fy2024. Fulgent's precision diagnostics business is growing nicely. The diagnostic company has a wildcard in its pipeline of paclitax-007.
Seeking Alpha · 5d ago
The 3 Best Digital Health Stocks for Personalized Medicine
NASDAQ · 11/28 00:07
Weekly Report: what happened at FLGT last week (1120-1124)?
Weekly Report · 11/27 10:53
Fulgent Genetics: Statement of changes in beneficial ownership of securities
Press release · 11/20 23:04
More
About FLGT
Fulgent Genetics, Inc. is a technology-based company with a clinical diagnostic business and a therapeutic development business. The Company's clinical diagnostic business offers molecular diagnostic testing services, genetic testing, and anatomic pathology laboratory services designed to provide physicians and patients with clinically actionable diagnostic information. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its business is built on its technology platform, which includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The Company's technology platform offers a test menu. The Company also offers next-generation sequencing (NGS) services.

Webull offers Fulgent Genetics Inc stock information, including NASDAQ: FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.